Medicare Enrolled
Dr. Mukaram Gazi, M.D.
Urology Physician · Hamilton, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gazi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gazi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gazi
Dr. Mukaram Gazi is an urology physician in Hamilton, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gazi performed 15,233 Medicare services across 4,930 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gazi received a total of $5,368 from 27 pharmaceutical and/or device companies across 133 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gazi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 4% volume in NJ
$5,368 industry payments
Medicare Practice Summary
Medicare Utilization ↗15,233
Medicare services
Top 4% in NJ for urology physician
4,930
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~762 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
5,759 | $34 | $117 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
2,215 | $34 | $80 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
1,324 | $69 | $80 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
724 | $103 | $440 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
443 | $34 | $74 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
443 | $34 | $74 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
442 | $34 | $58 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
441 | $34 | $80 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
440 | $34 | $75 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
341 | $0 | $160 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
308 | $3 | $11 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
293 | $9 | $275 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
279 | $76 | $259 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
233 | $777 | $3,850 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
167 | $10 | $348 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
155 | $66 | $400 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
143 | $133 | $675 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
123 | $206 | $1,863 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
89 | $101 | $259 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
82 | $33 | $195 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
63 | $46 | $765 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
60 | $88 | $444 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
58 | $142 | $820 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
52 | $119 | $300 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
51 | $315 | $1,200 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
51 | $27 | $825 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
51 | $167 | $725 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
48 | $42 | $495 |
| Chemical application to prevent wound tissue regrowth A chemical agent is applied to a wound to inhibit the regrowth of tissue. This procedure focuses on the application of the substance to manage the wound bed. |
42 | $54 | $150 |
| Injection, garamycin, gentamicin, up to 80 mg | 42 | $2 | $10 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
39 | $1,130 | $3,943 |
| Complete pelvic ultrasound An imaging test using sound waves to create pictures of the organs and structures within the pelvis. |
32 | $93 | $260 |
| Complicated change of bladder tube A complex surgical procedure to replace or modify a urinary diversion tube or conduit. This involves intricate manipulation of the urinary tract to ensure proper drainage and function. |
22 | $107 | $480 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
22 | $48 | $180 |
| Injection to cause erection A procedure involving an injection administered to induce an erection. |
21 | $72 | $650 |
| Ultrasound of penis artery and vein blood flow An ultrasound exam that uses sound waves to visualize and assess blood flow through the arteries and veins of the penis. |
21 | $91 | $806 |
| Electronic analysis of implanted neurostimulator with complex programming This procedure involves the electronic evaluation of an implanted neurostimulator generator. It includes complex programming of spinal cord or peripheral nerve stimulators. |
21 | $46 | $450 |
| Imaging guidance for procedure, 60 minutes or less Use of imaging technology to guide a medical procedure. This service lasts 60 minutes or less. |
19 | $13 | $300 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
18 | $99 | $600 |
| Diagnostic exam of anus and rectum under anesthesia A medical examination of the anus and rectum performed while the patient is under anesthesia. This allows for a thorough inspection without causing discomfort. |
16 | $47 | $440 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
16 | $54 | $681 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
12 | $46 | $740 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
12 | $18 | $125 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,368
Total received (2018-2024)
Avg $767/year across 7 years
Top 22% in NJ for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
133
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,168 (96.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$200 (3.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$833
2023
$1,132
2022
$499
2021
$144
2020
$713
2019
$1,530
2018
$517
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$458
Dendreon Pharmaceuticals LLC
$224
Boston Scientific Corporation
$44
Ferring Pharmaceuticals Inc.
$40
Astellas Pharma US Inc
$20
Sumitomo Pharma America, Inc.
$17
C. R. Bard, Inc. & Subsidiaries
$16
Bayer Healthcare Pharmaceuticals Inc.
$16
Top 3 companies account for 87.1% of 2024 payments
All-time payments by company (2018-2024) ›
PROCEPT BioRobotics Corporation
$1,385
Medtronic, Inc.
$1,358
Medtronic USA, Inc.
$492
Coloplast Corp
$322
Baxter Healthcare
$242
Teleflex LLC
$227
Boston Scientific Corporation
$225
Dendreon Pharmaceuticals LLC
$224
C. R. Bard, Inc. & Subsidiaries
$160
Astellas Pharma US Inc
$120
BOSTON SCIENTIFIC CORPORATION
$106
Endo Pharmaceuticals Inc.
$100
NeoTract Inc.
$76
Axonics Modulation Technologies, Inc.
$66
Hollister Incorporated
$40
Ferring Pharmaceuticals Inc.
$40
Sumitomo Pharma America, Inc.
$33
FUJIFILM Medical Systems USA, Inc.
$22
UROGEN PHARMA, INC.
$21
Antares Pharma, Inc.
$17
Bayer Healthcare Pharmaceuticals Inc.
$16
Allergan Inc.
$15
Myriad Genetic Laboratories, Inc.
$14
AbbVie, Inc.
$14
Rochester Medical Corporation
$12
Janssen Biotech, Inc.
$12
AbbVie Inc.
$12
Top 3 companies account for 60.3% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AMS · AQUABEAM ROBOTIC SYSTEM · AquaBeam Robotic System · Axonics r-SNM System · BOTOX · Bard Urinary Drainage Bag · ESD - Core Endoscopy · Erleada · FLOSEAL · GENERAL BPH · GENERAL - PAIN MANAGEMENT · GENERAL BPH · GENERAL ERECTILE DYSFUNCTION · INTERSTIM · JELMYTO · LUPRON DEPOT · Lupron Depot · NOCDURNA · Nubeqa · ORGOVYX · Onli · PROVENGE · Prolaris · REZUM · SUPERION · SpaceOAR VUE System - 10mL · SpeediCath · TITAN · UROLIFT · UroLift · UroLift System · VaPro · XIAFLEX · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
129
Per 100K population
33.7
County median income
$96,333
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL AT HAMILTON
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gazi is a mixed practice specialist, with above-average Medicare volume (top 4% in NJ), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gazi experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Gazi performed 5,759 infectious disease dna/rna test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gazi receive payments from pharmaceutical companies?
Yes. Dr. Gazi received a total of $5,368 from 27 companies across 133 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gazi's costs compare to other urology physicians in Hamilton?
Dr. Gazi's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gazi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Hamilton
Browse urology physicians in Hamilton ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NJ
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NJ
Which NJ urology physicians receive the most from drug and device companies.
By company
PROCEPT BioRobotics Corporation Payments to Doctors
See all physicians who received payments from PROCEPT BioRobotics Corporation.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology